203 related articles for article (PubMed ID: 25908103)
1. IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study.
Kao JT; Feng CL; Yu CJ; Tsai SM; Hsu PN; Chen YL; Wu YY
BMC Gastroenterol; 2015 Apr; 15():50. PubMed ID: 25908103
[TBL] [Abstract][Full Text] [Related]
2. IL-6 significantly correlates with p-STAT3 expression and presents high variceal bleeding with mortality in cirrhotic patients: A cross-sectional study.
Kao JT; Yu CJ; Feng CL; Tsai SM; Chen YL; Wu YY
J Microbiol Immunol Infect; 2017 Jun; 50(3):286-296. PubMed ID: 25899133
[TBL] [Abstract][Full Text] [Related]
3. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
[TBL] [Abstract][Full Text] [Related]
4. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
Helaly GF; Abou Shamaa LA
Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
[TBL] [Abstract][Full Text] [Related]
5. IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling.
Pu XY; Zheng DF; Shen A; Gu HT; Wei XF; Mou T; Zhang JB; Liu R
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):408-415. PubMed ID: 30201411
[TBL] [Abstract][Full Text] [Related]
6. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
7. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
[TBL] [Abstract][Full Text] [Related]
8. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
9. Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients.
Kao JT; Lai HC; Tsai SM; Lin PC; Chuang PH; Yu CJ; Cheng KS; Su WP; Hsu PN; Peng CY; Wu YY
Liver Int; 2012 Jul; 32(6):928-36. PubMed ID: 22230324
[TBL] [Abstract][Full Text] [Related]
10. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection.
Ataseven H; Bahcecioglu IH; Kuzu N; Yalniz M; Celebi S; Erensoy A; Ustundag B
Mediators Inflamm; 2006; 2006(4):78380. PubMed ID: 17047295
[TBL] [Abstract][Full Text] [Related]
11. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
12. Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection.
Tsai IT; Wang CP; Yu TH; Lu YC; Lin CW; Lu LF; Wu CC; Chung FM; Lee YJ; Hung WC; Hsu CC
Cytokine; 2017 Feb; 90():54-59. PubMed ID: 27770715
[TBL] [Abstract][Full Text] [Related]
13. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
[TBL] [Abstract][Full Text] [Related]
14. Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance.
Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ren WH; Ge YS; Yu JH; Liu WB; Wang W
J Surg Res; 2012 May; 174(1):120-9. PubMed ID: 21316706
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
[TBL] [Abstract][Full Text] [Related]
16. IL-17 Activates the IL-6/STAT3 Signal Pathway in the Proliferation of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Hu Z; Luo D; Wang D; Ma L; Zhao Y; Li L
Cell Physiol Biochem; 2017; 43(6):2379-2390. PubMed ID: 29073625
[TBL] [Abstract][Full Text] [Related]
17. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
[TBL] [Abstract][Full Text] [Related]
18. Liver Transplantation for Non-B and Non-C Hepatocellular Carcinoma.
Kaido T; Mori A; Ogura Y; Hata K; Yoshizawa A; lida T; Yagi S; Uemoto S
Hepatogastroenterology; 2015 Jun; 62(140):933-6. PubMed ID: 26902031
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.
Jiang R; Tan Z; Deng L; Chen Y; Xia Y; Gao Y; Wang X; Sun B
Hepatology; 2011 Sep; 54(3):900-9. PubMed ID: 21674558
[TBL] [Abstract][Full Text] [Related]
20. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
